Information Provided By: 
Fly News Breaks for February 28, 2018
BIO
Feb 28, 2018 | 07:19 EDT
Jefferies analyst Brandon Couillard raised his price target for Bio-Rad Laboratories to $325 saying the second half of 2017 margin ramp and initial 2018 outlook "should quell debate" over the company's ability to execute and the relevancy of its 2020 goals. Couillard says Bio-Rad remains his top pick and the "most compelling absolute value we can find." He keeps a Buy rating on the shares following the company's Q4 results.
News For BIO From the Last 2 Days
There are no results for your query BIO
